|

Arthritis Clinical Trials in Phoenix, AZ

36 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic DrugPhase 3<1 mi
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseasePhase 4<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesPhase 3<1 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Phase 4<1 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 3<1 mi
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic ArthritisPhase 3<1 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneePhase 3<1 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainPhase 2<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPhase 3<1 mi
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.Phase 2<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—<1 mi
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.Phase 3<1 mi
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid ArthritisPhase 1<1 mi
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement—<1 mi
Innovations in Genicular Outcomes Registry—<1 mi
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 39 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)Phase 39 mi
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)Phase 29 mi
Study of Dapansutrile Tablets in Subjects With an Acute Gout FlarePhase 2/39 mi
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic ArthritisPhase 39 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisPhase 29 mi
At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]N/A9 mi
Study of Single Doses of SBT777101 in Subjects With Rheumatoid ArthritisPhase 111 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee OsteoarthritisEarly 111 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar PainPhase 111 mi
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune DiseasesPhase 211 mi
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsPhase 113 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.Phase 313 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisPhase 213 mi
RA-PRO PRAGMATIC TRIALPhase 313 mi
Safety and Efficacy of ABP-745 in Participants With an Acute Gout FlarePhase 213 mi
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)Phase 213 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightPhase 315 mi
A Study of SPY072 in Rheumatic DiseasePhase 216 mi
FX Shoulder Prospective Clinical Study—18 mi
FX Shoulder Solutions Retrospective / Prospective Clinical Study—18 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.